Ratio de rentabilidad sobre activos (ROA)
desde 2005
Cálculo
Merck & Co. Inc., ROA, tendencias a largo plazocálculo
| ROA | = | 100 | × | Utilidad neta atribuible a Merck & Co., Inc.1 | ÷ | Activos totales1 | |
|---|---|---|---|---|---|---|---|
| 31 dic 2024 | 14.62% | = | 100 | × | 17,117) | ÷ | 117,106) |
| 31 dic 2023 | 0.34% | = | 100 | × | 365) | ÷ | 106,675) |
| 31 dic 2022 | 13.30% | = | 100 | × | 14,519) | ÷ | 109,160) |
| 31 dic 2021 | 12.35% | = | 100 | × | 13,049) | ÷ | 105,694) |
| 31 dic 2020 | 7.72% | = | 100 | × | 7,067) | ÷ | 91,588) |
| 31 dic 2019 | 11.66% | = | 100 | × | 9,843) | ÷ | 84,397) |
| 31 dic 2018 | 7.53% | = | 100 | × | 6,220) | ÷ | 82,637) |
| 31 dic 2017 | 2.72% | = | 100 | × | 2,394) | ÷ | 87,872) |
| 31 dic 2016 | 4.11% | = | 100 | × | 3,920) | ÷ | 95,377) |
| 31 dic 2015 | 4.36% | = | 100 | × | 4,442) | ÷ | 101,779) |
| 31 dic 2014 | 12.12% | = | 100 | × | 11,920) | ÷ | 98,335) |
| 31 dic 2013 | 4.17% | = | 100 | × | 4,404) | ÷ | 105,645) |
| 31 dic 2012 | 5.81% | = | 100 | × | 6,168) | ÷ | 106,132) |
| 31 dic 2011 | 5.97% | = | 100 | × | 6,272) | ÷ | 105,128) |
| 31 dic 2010 | 0.81% | = | 100 | × | 861) | ÷ | 105,781) |
| 31 dic 2009 | 11.51% | = | 100 | × | 12,901) | ÷ | 112,090) |
| 31 dic 2008 | 16.54% | = | 100 | × | 7,808) | ÷ | 47,196) |
| 31 dic 2007 | 6.77% | = | 100 | × | 3,275) | ÷ | 48,351) |
| 31 dic 2006 | 9.95% | = | 100 | × | 4,434) | ÷ | 44,570) |
| 31 dic 2005 | 10.33% | = | 100 | × | 4,631) | ÷ | 44,846) |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
1 US$ en millones
Comparación con la competencia
Merck & Co. Inc., ROA, tendencias a largo plazo, comparación con los competidores
| Merck & Co. Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 dic 2024 | 14.62% | 3.17% | 4.45% | -9.66% | 5.03% | 13.45% | 0.81% | 7.81% | 3.76% | 11.69% | 6.51% | -2.38% |
| 31 dic 2023 | 0.34% | 3.61% | 6.91% | 8.43% | 5.64% | 8.19% | 9.12% | 20.98% | 0.94% | 11.95% | 6.07% | 15.92% |
| 31 dic 2022 | 13.30% | 8.53% | 10.06% | 6.53% | 8.55% | 12.62% | 7.27% | 9.57% | 15.91% | 14.85% | 7.15% | 18.30% |
| 31 dic 2021 | 12.35% | 7.88% | 9.63% | 6.40% | 7.73% | 11.44% | 9.16% | 11.47% | 12.11% | 31.75% | 8.12% | 17.44% |
| 31 dic 2020 | 7.72% | 3.07% | 11.54% | -7.61% | 4.79% | 13.28% | 0.18% | 8.41% | 6.23% | 20.47% | 9.23% | 23.07% |
| 31 dic 2019 | 11.66% | 8.84% | 13.13% | 2.65% | 4.85% | 21.17% | 8.74% | 9.59% | 9.72% | 14.29% | 6.33% | 14.15% |
| 31 dic 2018 | 7.53% | 9.58% | 12.64% | 14.06% | 5.54% | 7.36% | 8.57% | 10.00% | 7.00% | 20.83% | 5.22% | 33.57% |
| 31 dic 2017 | 2.72% | 7.50% | 2.48% | 3.00% | 5.34% | -0.45% | 6.58% | 0.83% | 12.40% | 13.67% | 3.93% | 7.43% |
| 31 dic 2016 | 4.11% | 9.01% | 9.95% | 13.22% | 5.64% | 7.05% | 23.70% | 11.71% | 4.20% | 12.84% | 4.40% | -3.87% |
| 31 dic 2015 | 4.36% | 9.70% | 9.69% | 4.93% | 6.96% | 6.77% | 34.93% | 11.55% | 4.16% | 11.34% | 4.83% | -22.26% |
| 31 dic 2014 | 12.12% | 6.44% | 7.47% | 5.94% | 7.02% | 6.43% | 34.91% | 12.45% | 5.40% | 8.99% | 4.42% | -31.63% |
| 31 dic 2013 | 4.17% | 14.14% | 7.68% | 6.64% | 7.77% | 13.29% | 13.67% | 10.42% | 12.78% | 14.38% | 4.00% | -19.19% |
| 31 dic 2012 | 5.81% | 19.53% | 8.00% | 5.46% | 7.26% | 11.89% | 12.20% | 8.94% | 7.84% | 36.06% | 4.29% | -3.88% |
| 31 dic 2011 | 5.97% | — | 7.54% | 11.25% | 7.25% | 12.92% | 16.20% | 8.51% | 5.32% | -16.75% | 4.96% | 1.34% |
| 31 dic 2010 | 0.81% | — | 10.64% | 9.98% | 8.07% | 16.35% | 25.03% | 12.96% | 4.23% | -9.59% | 4.85% | -43.74% |
| 31 dic 2009 | 11.51% | — | 11.62% | 34.22% | 5.88% | 15.76% | 27.18% | 12.95% | 4.05% | -9.15% | 3.93% | -32.84% |
| 31 dic 2008 | 16.54% | — | 11.51% | 17.76% | 7.53% | -7.09% | 28.65% | 15.25% | 7.29% | -12.34% | 4.71% | -46.90% |
| 31 dic 2007 | 6.77% | — | 9.14% | 8.27% | 7.84% | 11.02% | 27.68% | 13.06% | 7.07% | -11.28% | 3.59% | -65.05% |
| 31 dic 2006 | 9.95% | — | 8.73% | 6.20% | 8.72% | 12.13% | -29.12% | 15.67% | 16.84% | -17.49% | 0.79% | -22.45% |
| 31 dic 2005 | 10.33% | — | 12.54% | 10.66% | 9.80% | 8.05% | 21.62% | 17.94% | 6.88% | -22.54% | 5.25% | -37.05% |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
Comparativa con el sector industrial: Productos farmacéuticos, biotecnología y ciencias de la vida
Merck & Co. Inc., ROA, tendencias a largo plazo, en comparación con el sector industrial: productos farmacéuticos, biotecnología y ciencias de la vida
| Merck & Co. Inc. | Productos farmacéuticos, biotecnología y ciencias de la vida | |
|---|---|---|
| 31 dic 2024 | 14.62% | 5.30% |
| 31 dic 2023 | 0.34% | 7.25% |
| 31 dic 2022 | 13.30% | 10.67% |
| 31 dic 2021 | 12.35% | 10.42% |
| 31 dic 2020 | 7.72% | 5.45% |
| 31 dic 2019 | 11.66% | 9.02% |
| 31 dic 2018 | 7.53% | 8.97% |
| 31 dic 2017 | 2.72% | 5.28% |
| 31 dic 2016 | 4.11% | 8.61% |
| 31 dic 2015 | 4.36% | 8.93% |
| 31 dic 2014 | 12.12% | 9.45% |
| 31 dic 2013 | 4.17% | 9.46% |
| 31 dic 2012 | 5.81% | 8.30% |
| 31 dic 2011 | 5.97% | 7.30% |
| 31 dic 2010 | 0.81% | 7.07% |
| 31 dic 2009 | 11.51% | 10.02% |
| 31 dic 2008 | 16.54% | 10.37% |
| 31 dic 2007 | 6.77% | 8.86% |
| 31 dic 2006 | 9.95% | 11.91% |
| 31 dic 2005 | 10.33% | 10.42% |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
Comparación con la industria: Atención médica
Merck & Co. Inc., ROA, tendencias a largo plazo, en comparación con la industria: atención médica
| Merck & Co. Inc. | Atención médica | |
|---|---|---|
| 31 dic 2024 | 14.62% | 5.25% |
| 31 dic 2023 | 0.34% | 6.71% |
| 31 dic 2022 | 13.30% | 8.71% |
| 31 dic 2021 | 12.35% | 8.70% |
| 31 dic 2020 | 7.72% | 5.45% |
| 31 dic 2019 | 11.66% | 7.57% |
| 31 dic 2018 | 7.53% | 6.72% |
| 31 dic 2017 | 2.72% | 5.31% |
| 31 dic 2016 | 4.11% | 7.18% |
| 31 dic 2015 | 4.36% | 7.54% |
| 31 dic 2014 | 12.12% | 8.41% |
| 31 dic 2013 | 4.17% | 8.58% |
| 31 dic 2012 | 5.81% | 7.94% |
| 31 dic 2011 | 5.97% | 7.22% |
| 31 dic 2010 | 0.81% | 7.11% |
| 31 dic 2009 | 11.51% | 9.45% |
| 31 dic 2008 | 16.54% | 9.08% |
| 31 dic 2007 | 6.77% | 8.51% |
| 31 dic 2006 | 9.95% | 10.37% |
| 31 dic 2005 | 10.33% | 9.62% |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).